Alda-1 Alleviates The Cognitive Deficits In D-Galactose-Induced Aging Mice By Regulating Oxidative Stress, Neuroinflammation, And Mitochondrial Biogenesis
As we age, our brains can experience a decline in cognitive function, often linked to factors like increased oxidative stress and inflammation. Recent research explored a potential way to combat these age-related changes using a compound called Alda-1. This compound works by activating a specific enzyme in our cells, mitochondrial aldehyde dehydrogenase 2 (ALDH2), which plays a role in cellular health and aging.
In a study using mice with induced aging, which mimics some aspects of human aging, treatment with Alda-1 led to significant improvements in cognitive abilities. The researchers observed that the compound helped to reduce harmful oxidative stress, a process where unstable molecules damage cells, and also lowered levels of neuroinflammation, which is inflammation within the brain. Furthermore, Alda-1 promoted mitochondrial biogenesis, essentially helping the brain create more mitochondria, the “powerhouses” of our cells that generate energy. These positive effects were linked to the modulation of a specific cellular pathway known as SIRT1/PGC-1α, which is crucial for cell protection and energy metabolism. This suggests that targeting ALDH2 could be a promising strategy for addressing age-related cognitive decline.
Source: link to paper